Vir Biotechnology (VIR) Enterprise Value: 1.470B

Vir Biotechnology, Inc. (VIR)

11.30 -0.45 (-3.83%) USD | NASDAQ | Oct 30, 16:00

11.46 +0.16 (+1.42%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2019. Start Trial.

Date	Value
October 30, 2026	1.470B
October 29, 2026	1.547B
October 28, 2026	1.577B
October 27, 2026	1.516B
October 26, 2026	1.426B
October 23, 2026	1.347B
October 22, 2026	1.323B
October 21, 2026	1.347B
October 20, 2026	1.376B
October 19, 2026	1.286B
October 16, 2026	1.244B
October 15, 2026	1.330B
October 14, 2026	1.320B
October 13, 2026	1.354B
October 12, 2026	1.470B
October 09, 2026	1.538B
October 08, 2026	1.440B
October 07, 2026	1.508B
October 06, 2026	1.521B
October 05, 2026	1.552B
October 02, 2026	1.448B
October 01, 2026	1.469B
September 30, 2026	1.450B
September 29, 2026	1.360B
September 28, 2026	1.337B

Date	Value
September 25, 2026	1.362B
September 24, 2026	1.372B
September 23, 2026	1.435B
September 22, 2026	1.504B
September 21, 2026	1.399B
September 18, 2026	1.352B
September 17, 2026	1.406B
September 16, 2026	1.338B
September 15, 2026	1.325B
September 14, 2026	1.380B
September 11, 2026	1.355B
September 10, 2026	1.349B
September 09, 2026	1.388B
September 08, 2026	1.450B
September 04, 2026	1.485B
September 03, 2026	1.496B
September 02, 2026	1.504B
September 01, 2026	1.526B
August 31, 2026	1.410B
August 28, 2026	1.391B
August 27, 2026	1.472B
August 26, 2026	1.433B
August 25, 2026	1.371B
August 24, 2026	1.235B
August 21, 2026	1.213B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks